netFormulary Dorset NHS
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
Poole Hospital NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Welcome to the Dorset Formulary

Useful Links

Dorset Medicines Advisory Group (DMAG)

DMAG Summary

Traffic Light Categorisation

Formulary Proposal Form

Shared Care Guideline Template 

 Drug Decision Making Process        

Primary Care

Opioid Resource Pack

SCAN Guidelines (Antibiotics)

Understanding your urine microbiology results (MSU)

SPS guidance on alternatives to solid dosage forms

CQC matrix

Medicines Optimisation Plan (including audits and savings plan)

Dorset CCG Medicines Standards

NHSE Medicines Shortage Guidance

SPS - Shortages

DHSC - Shortages

GSK shortages

MIMS Drug shortages - live tracker

Private Prescription Guidance

Private Prescription – Items Cheaper Than a Prescription Charge 

NHSE OTC patient information leaflet

NHSE OTC Letter for GPs

NHSE OTC support document

Medicines Matters: mechanisms for prescribing, supply and administration of medicines

Template Letter to Decline prescribing of "red" drugs in Primary Care

Template Letter to Decline Prescribing of "non-formulary" drugs in Primary Care 

 Resources for Specials Prescribing


Over the counter items - GP guide to self care (PrescQIPP log in required)


Secondary Care

Individual Funding Requests (NHSE)

CCG Notification of High Cost Excluded Drugs

Cancer Drug Fund (CDF) List

NHS England High Cost Drug List

Individual Funding Requests (CCG)

The Manual NHS England


Useful Websites

Yellow Card Scheme

Polypharmacy Formulary Chapter

NICE Evidence Search/ BNF

Drug Tariff

NHS Choices Patient Medicine Leaflets

Electronic Medicines Compendium (eMC)

OTC Directory

CCG Incident Reporting Tool

SPS: Excipients: What are the general considerations for vegan patients? Central Alerting System (CAS) homepage     


News Feed

16th October - Ranitidine supply issue 

  • All oral formulations of ranitidine are anticipated to be out of stock, with no date for resupply until further notice.

  • An investigation by the Swiss and German regulatory agencies and the US Food and Drug Administration (FDA), has identified a contaminant, N-nitrosodimethylamine (NDMA), in samples of ranitidine active substance.

  • All stock manufactured for the UK using the affected ranitidine active substance has been quarantined, whilst Medicines and Healthcare products Regulatory Agency (MHRA) investigations are ongoing.
  • Although all oral formulations are expected to be out of stock, very limited supplies of unaffected oral ranitidine products may remain available and should be reserved for those patients in whom alternatives are not clinically appropriate.
  • All other patients should be reviewed as repeat prescriptions are requested, and if ongoing treatment is required, be switched to clinical alternatives.
  • Please see the CAS alert for details about actions required and alternatives

14th October 2019 - Updates to shortages

Phenelzine now unavailable until March 2020 (see drug entry for details)

Adrenaline auto-injectors

  • Emerade supplies expected w/c 14th October
  • Reports of Emerade auto-injectors failing to activate, patients must carry two pens at all times
  • Some batches of EpiPen and Jext have had their expiry dates extended - see and for details
  • Further details can be found here (N3 connection required)

11th October

Serious shortage protocols for fluoxetine

Serious shortage protocols are available for use with the fluoxetine capsule shortage see here.


UPDATE: Ranitidine products linked to impurity and carcinogen (NDMA).

Zantac – MHRA drug alert issued as GlaxoSmithKline recalls all unexpired pharmacy stock.

At present patients and healthcare professionals are advised to continue using their medicines as normal. The health risk of discontinuing the medicine is higher than the potential risk presented by the contaminant. Currently there is no evidence that medicines containing the impurity have caused any harm to patients but the MHRA is closely monitoring the situation. Patients do not need to see their Doctor until their next routine appointment, but should seek their doctor’s advice if they have any concerns.

An MHRA investigation into other brands of ranitidine medicines which may also be affected is continuing and further updates will be provided as this investigation progresses. Currently other ranitidine products have not been recalled.

Shortages update 30th September 2019

  • Loestrin 20 and 30 have been discontinued by the manufacturer
  • Noriday is now back in stock
  • EpiPen Junior is now subject to prescription validation process

Shortage update 24th September 2019 - manufacturing delays

Both strengths of capsaicain cream will be out of stock until at least November 2019. For more information click here (commercially sensitive, N3 connection only)

Both strengths of mianserin are out of stock until the end of 2019. For more information click here (commercially sensitive, N3 connection only). 

All strengths of tiagabine will be out of stock until the end of October 2019. For more information click here (commercially sensitive, N3 connection only). 

>>> more news

Getting started: Use the search tool to find medicine of interest or browse by BNF chapter using the 'Chapters' Menu at top of page.

The Dorset Formulary aims to provide information on medicines supporting safe, evidence-based, cost-effective practice. Whilst the formulary contains links to relevant policies and guidelines, the prescriber retains the responsibility for the appropriate use of this information.

For further information on the development of the Dorset Formulary and participating organisations, please go to the About page. 

Comments about any aspect of the formulary can be made by using the feedback tab at the top of this page.

   Visits = 133967
   Last updated: 16/10/2019 13:44:52
    Download net formulary from Apple IOS Store  Google Play net formulary